Growth Opportunities in APAC Oncology Diagnostics Market, Forecast to 2021

Growth Opportunities in APAC Oncology Diagnostics Market, Forecast to 2021

Innovation, Technology Integration, and New Customer Segments to Drive New Business Growth

RELEASE DATE
06-Jul-2017
REGION
Asia Pacific
Research Code: P9A4-01-00-00-00
SKU: HC02838-AP-MT_20335

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02838-AP-MT_20335

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

There is high growth in the Asia-Pacific (APAC) oncology diagnostics market due to increasing incidence of cancer and the drastic reduction in incidence age owing to a plethora of reasons in the regional market. The major drivers for the APAC cancer diagnostics market are increase in adoption of technology platforms, access to targeted cancer therapeutics and increased demand from patients for affordable and quality care. Furthermore, the global push toward precision medicine has gradually propelled the uptake of innovative platforms such as Next-generation Sequencing (NGS) and liquid biopsy for gradual adoption into mainstream clinical diagnosis. The study examines the APAC oncology diagnostics market, focused on 6 high-prevalence cancers, namely, breast, lung, prostate, colorectal, cervical, and ovarian cancer. The scope of the study includes 10 countries: Japan, China, India, South Korea, Australia, Singapore, Malaysia, Indonesia, Thailand, and Vietnam, with country-level market share and top trends and opportunities driving the oncology diagnostics market. Furthermore, the study identifies the top growth opportunities and market trends that are set to transform the future landscape of oncology diagnostics in APAC. NGS solutions are gradually moving from research to clinical applications, with major regional companies investing in molecular diagnostics as a future growth segment. Luye Pharma’s acquisition of Vela Diagnostics, the Genome Asia 100K initiative by Macrogen, multiplexed diagnostic solutions from Seegene Diagnostics, and liquid biopsy tools from Sysmex Inostics are a few examples of trending topics in APAC that will impact the oncology diagnostics market. The market, whose revenue stood at $873.7 million in 2016, is expected to generate a revenue of $1,149.1 million by 2021, growing at a Compound Annual Growth Rate (CAGR) of 5.6%.

In addition to the above-mentioned data points, the study also provides information in terms of the key participants across the market by different cancer types as well as some of the new entrants in the market.

The following are some key questions that this study will answer.
•     What is the current market scenario for oncology diagnostics in Asia?
•     What are the emerging cancers in Asia with high-growth opportunities in In-vitro Diagnostics (IVD)?
•     What are the regional dynamics currently trending in Asia to combat the rising prominence of cancer, precisely through early screening and surveillance programs?
•     What is the penetration of novel diagnostic solutions across the oncology care continuum?
•     What are the challenges and barriers to address in accelerating the uptake of novel screening or cancer diagnostic tests in Asia?
•     What are the growth opportunities for IVD companies to tap into in the APAC oncology diagnostics market?

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Purpose of This APAC Oncology Diagnostics Study

5-Step Process to Transformational Growth

Strategic Imperatives for APAC OncoDx Companies

Market Segmentation

Key Findings—How is This Market Important to You?

8 Big Market Themes for APAC Oncology Dx

Market Size Estimation Methodology

Market Overview

Industry Value Chain

Market Drivers and Restraints

Trends in APAC Oncology Diagnostics Market

Key Companies to Watch

China

India

Japan

South Korea

Australia

ASEAN

Growth Opportunity Matrix

Key Growth Opportunities—Preview

Growth Opportunity 1—Artificial Intelligence (AI)

Growth Opportunity 2—Vertical Investments

Growth Opportunity 3—Frugal Innovation in Cancer Screening

Growth Opportunity 4—Emerging Biomarkers

Growth Opportunity 5—Digital Solutions

Growth Opportunity 6—Emerging Markets

Companion Diagnostics—An Opportunity

Market Overview

Market Segmentation by Technology

Revenue Forecast by Technology Type

Percent Revenue Breakdown by Country

Competitor Scenario and Market Share Analysis

Key Companies to Watch

Emerging Technologies in Breast Cancer Diagnostics

Market Overview

Market Segmentation by Technology

Revenue Forecast by Technology Type

Percent Revenue Breakdown by Country

Competitor Scenario and Market Share Analysis

Key Companies to Watch

Emerging Technologies in Lung Cancer Diagnostics

Market Overview

Market Segmentation by Technology

Revenue Forecast by Technology Type

Percent Revenue Breakdown by Country

Competitor Scenario and Market Share Analysis

Key Companies to Watch

Emerging Technologies in Colorectal Cancer Diagnostics

Market Overview

Market Segmentation by Technology

Revenue Forecast by Technology Type

Percent Revenue Breakdown by Country

Competitor Scenario and Market Share Analysis

Key Companies to Watch

Emerging Technologies in Ovarian Cancer Diagnostics

Market Overview

Market Segmentation by Technology

Revenue Forecast by Technology Type

Percent Revenue Breakdown by Country

Competitor Scenario and Market Share Analysis

Key Companies to Watch

Emerging Technologies in Cervical Cancer Diagnostics

Market Overview

Market Segmentation by Technology

Revenue Forecast by Technology Type

Percent Revenue Breakdown by Country

Competitor Scenario and Market Share Analysis

Key Companies to Watch

Emerging Technologies in Prostate Cancer Diagnostics

5 Competitive Keys for Success in APAC Cancer Diagnostic Space

Legal Disclaimer

List of Figures
  • 1. Oncology Diagnostics Market: Industry Value Chain, APAC, 2016
  • 2. Oncology Diagnostics Market: Key Market Drivers and Restraints, APAC, 2017–2021
  • 3. Oncology Diagnostics Market: Cancer Diagnostics Technology, APAC, 2016–2021
  • 4. Oncology Diagnostics Market: Technology Penetration by Cancer type, APAC, 2016
  • 5. Oncology Diagnostics Market: Companion Diagnostics—An Opportunity, APAC, 2016
  • 6. Breast Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016
  • 7. Breast Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016
  • 8. Breast Cancer Diagnostics Market: Emerging Technologies, APAC, 2016
  • 9. Lung Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016
  • 10. Lung Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016
  • 11. Lung Cancer Diagnostics Market: Emerging Technologies, APAC, 2016
  • 12. Colorectal Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016
  • 13. Colorectal Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016
  • 14. Colorectal Cancer Diagnostics Market: Emerging Technologies, APAC, 2016
  • 15. Ovarian Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016
  • 16. Ovarian Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016
  • 17. Ovarian Cancer Diagnostics Market: Emerging Technologies, APAC, 2016
  • 18. Cervical Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016
  • 19. Cervical Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016
  • 20. Cervical Cancer Diagnostics Market: Emerging Technologies, APAC, 2016
  • 21. Prostate Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016
  • 22. Prostate Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016
  • 23. Prostate Cancer Diagnostics Market: Emerging Technologies, APAC, 2016
List of Charts
  • 1. Oncology Diagnostics Market: Revenue Share by Cancer Type, APAC, 2016–2021
  • 2. Oncology Diagnostics Market: Percent Revenue Breakdown by Cancer Type, APAC, 2016 and 2021
  • 3. Oncology Diagnostics Market: Growth Opportunity Matrix, APAC, 2016–2021
  • 4. Oncology Diagnostics Market: Breast Cancer Diagnostic Pathway, APAC, 2016
  • 5. Breast Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021
  • 6. Breast Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016
  • 7. Breast Cancer Diagnostics Market: Diagnostic Patterns, APAC, 2016
  • 8. Breast Cancer Diagnostics Market: Market Share Analysis, APAC, 2016
  • 9. Oncology Diagnostics Market: Lung Cancer Diagnostic Pathway, APAC, 2016
  • 10. Lung Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021
  • 11. Lung Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016
  • 12. Lung Cancer Diagnostics Market: Market Share Analysis, APAC, 2016
  • 13. Oncology Diagnostics Market: Colorectal Cancer Diagnostic Pathway, APAC, 2016
  • 14. Colorectal Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021
  • 15. Colorectal Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016
  • 16. Colorectal Cancer Diagnostics Market: Market Share Analysis, APAC, 2016
  • 17. Oncology Diagnostics Market: Ovarian Cancer Diagnostic Pathway, APAC, 2016
  • 18. Ovarian Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021
  • 19. Ovarian Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016
  • 20. Oncology Diagnostics Market: Ovarian Cancer Market Share Analysis, APAC, 2016
  • 21. Oncology Diagnostics Market: Cervical Cancer Diagnostic Pathway, APAC, 2016
  • 22. Cervical Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021
  • 23. Cervical Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016
  • 24. Cervical Cancer Diagnostics Market: Market Share Analysis, APAC, 2016
  • 25. Oncology Diagnostics Market: Prostate Cancer Diagnostic Pathway, APAC, 2016
  • 26. Prostate Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2016
  • 27. Prostate Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016
  • 28. Prostate Cancer Diagnostics Market: Market Share Analysis, APAC, 2016
Related Research
There is high growth in the Asia-Pacific (APAC) oncology diagnostics market due to increasing incidence of cancer and the drastic reduction in incidence age owing to a plethora of reasons in the regional market. The major drivers for the APAC cancer diagnostics market are increase in adoption of technology platforms, access to targeted cancer therapeutics and increased demand from patients for affordable and quality care. Furthermore, the global push toward precision medicine has gradually propelled the uptake of innovative platforms such as Next-generation Sequencing (NGS) and liquid biopsy for gradual adoption into mainstream clinical diagnosis. The study examines the APAC oncology diagnostics market, focused on 6 high-prevalence cancers, namely, breast, lung, prostate, colorectal, cervical, and ovarian cancer. The scope of the study includes 10 countries: Japan, China, India, South Korea, Australia, Singapore, Malaysia, Indonesia, Thailand, and Vietnam, with country-level market share and top trends and opportunities driving the oncology diagnostics market. Furthermore, the study identifies the top growth opportunities and market trends that are set to transform the future landscape of oncology diagnostics in APAC. NGS solutions are gradually moving from research to clinical applications, with major regional companies investing in molecular diagnostics as a future growth segment. Luye Pharma’s acquisition of Vela Diagnostics, the Genome Asia 100K initiative by Macrogen, multiplexed diagnostic solutions from Seegene Diagnostics, and liquid biopsy tools from Sysmex Inostics are a few examples of trending topics in APAC that will impact the oncology diagnostics market. The market, whose revenue stood at $873.7 million in 2016, is expected to generate a revenue of $1,149.1 million by 2021, growing at a Compound Annual Growth Rate (CAGR) of 5.6%. In addition to the above-mentioned data points, the study also provides information in terms of the key participants acros
More Information
No Index No
Podcast No
Table of Contents | Executive Dashboard~ || Purpose of This APAC Oncology Diagnostics Study~ || 5-Step Process to Transformational Growth~ || Strategic Imperatives for APAC OncoDx Companies~ || Market Segmentation~ || Key Findings—How is This Market Important to You?~ || 8 Big Market Themes for APAC Oncology Dx~ | Growth Environment—Market Overview~ || Market Size Estimation Methodology~ || Market Overview~ || Industry Value Chain~ || Market Drivers and Restraints~ || Trends in APAC Oncology Diagnostics Market~ || Key Companies to Watch~ | Growth Environment—Market Forecasts~ || Revenue Forecast~ | Growth Environment—Regional Analysis~ || China~ || India~ || Japan~ || South Korea~ || Australia~ || ASEAN~ | Growth Pipeline, Strategy, and Implementation~ || Growth Opportunity Matrix~ || Key Growth Opportunities—Preview~ || Growth Opportunity 1—Artificial Intelligence (AI)~ || Growth Opportunity 2—Vertical Investments~ || Growth Opportunity 3—Frugal Innovation in Cancer Screening~ || Growth Opportunity 4—Emerging Biomarkers~ || Growth Opportunity 5—Digital Solutions~ || Growth Opportunity 6—Emerging Markets~ || Companion Diagnostics—An Opportunity~ | Breast Cancer~ || Market Overview~ || Market Segmentation by Technology~ || Revenue Forecast by Technology Type~ || Percent Revenue Breakdown by Country~ || Competitor Scenario and Market Share Analysis~ || Key Companies to Watch~ || Emerging Technologies in Breast Cancer Diagnostics~ | Lung Cancer~ || Market Overview~ || Market Segmentation by Technology~ || Revenue Forecast by Technology Type~ || Percent Revenue Breakdown by Country~ || Competitor Scenario and Market Share Analysis~ || Key Companies to Watch~ || Emerging Technologies in Lung Cancer Diagnostics~ | Colorectal Cancer~ || Market Overview~ || Market Segmentation by Technology~ || Revenue Forecast by Technology Type~ || Percent Revenue Breakdown by Country~ || Competitor Scenario and Market Share Analysis~ || Key Companies to Watch~ || Emerging Technologies in Colorectal Cancer Diagnostics~ | Ovarian Cancer~ || Market Overview~ || Market Segmentation by Technology~ || Revenue Forecast by Technology Type~ || Percent Revenue Breakdown by Country~ || Competitor Scenario and Market Share Analysis~ || Key Companies to Watch~ || Emerging Technologies in Ovarian Cancer Diagnostics~ | ~ | Cervical Cancer~ || Market Overview~ || Market Segmentation by Technology~ || Revenue Forecast by Technology Type~ || Percent Revenue Breakdown by Country~ || Competitor Scenario and Market Share Analysis~ || Key Companies to Watch~ || Emerging Technologies in Cervical Cancer Diagnostics~ | Prostate Cancer~ || Market Overview~ || Market Segmentation by Technology~ || Revenue Forecast by Technology Type~ || Percent Revenue Breakdown by Country~ || Competitor Scenario and Market Share Analysis~ || Key Companies to Watch~ || Emerging Technologies in Prostate Cancer Diagnostics~ | Conclusion~ || 5 Competitive Keys for Success in APAC Cancer Diagnostic Space~ || Legal Disclaimer~
List of Charts and Figures 1. Oncology Diagnostics Market: Industry Value Chain, APAC, 2016~ 2. Oncology Diagnostics Market: Key Market Drivers and Restraints, APAC, 2017–2021~ 3. Oncology Diagnostics Market: Cancer Diagnostics Technology, APAC, 2016–2021 ~ 4. Oncology Diagnostics Market: Technology Penetration by Cancer type, APAC, 2016~ 5. Oncology Diagnostics Market: Companion Diagnostics—An Opportunity, APAC, 2016~ 6. Breast Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016~ 7. Breast Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016~ 8. Breast Cancer Diagnostics Market: Emerging Technologies, APAC, 2016~ 9. Lung Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016~ 10. Lung Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016~ 11. Lung Cancer Diagnostics Market: Emerging Technologies, APAC, 2016~ 12. Colorectal Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016~ 13. Colorectal Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016~ 14. Colorectal Cancer Diagnostics Market: Emerging Technologies, APAC, 2016~ 15. Ovarian Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016~ 16. Ovarian Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016~ 17. Ovarian Cancer Diagnostics Market: Emerging Technologies, APAC, 2016~ 18. Cervical Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016~ 19. Cervical Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016~ 20. Cervical Cancer Diagnostics Market: Emerging Technologies, APAC, 2016~ 21. Prostate Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016~ 22. Prostate Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016~ 23. Prostate Cancer Diagnostics Market: Emerging Technologies, APAC, 2016~| 1. Oncology Diagnostics Market: Revenue Share by Cancer Type, APAC, 2016–2021~ 2. Oncology Diagnostics Market: Percent Revenue Breakdown by Cancer Type, APAC, 2016 and 2021~ 3. Oncology Diagnostics Market: Growth Opportunity Matrix, APAC, 2016–2021~ 4. Oncology Diagnostics Market: Breast Cancer Diagnostic Pathway, APAC, 2016~ 5. Breast Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021~ 6. Breast Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016 ~ 7. Breast Cancer Diagnostics Market: Diagnostic Patterns, APAC, 2016~ 8. Breast Cancer Diagnostics Market: Market Share Analysis, APAC, 2016~ 9. Oncology Diagnostics Market: Lung Cancer Diagnostic Pathway, APAC, 2016~ 10. Lung Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021~ 11. Lung Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016~ 12. Lung Cancer Diagnostics Market: Market Share Analysis, APAC, 2016~ 13. Oncology Diagnostics Market: Colorectal Cancer Diagnostic Pathway, APAC, 2016~ 14. Colorectal Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021~ 15. Colorectal Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016~ 16. Colorectal Cancer Diagnostics Market: Market Share Analysis, APAC, 2016~ 17. Oncology Diagnostics Market: Ovarian Cancer Diagnostic Pathway, APAC, 2016~ 18. Ovarian Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021~ 19. Ovarian Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016~ 20. Oncology Diagnostics Market: Ovarian Cancer Market Share Analysis, APAC, 2016~ 21. Oncology Diagnostics Market: Cervical Cancer Diagnostic Pathway, APAC, 2016~ 22. Cervical Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021~ 23. Cervical Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016~ 24. Cervical Cancer Diagnostics Market: Market Share Analysis, APAC, 2016~ 25. Oncology Diagnostics Market: Prostate Cancer Diagnostic Pathway, APAC, 2016~ 26. Prostate Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2016~ 27. Prostate Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016~ 28. Prostate Cancer Diagnostics Market: Market Share Analysis, APAC, 2016~
Author Shaillender Muthukumaraswamy
Industries Healthcare
WIP Number P9A4-01-00-00-00
Is Prebook No